IBrance Pharmaceutical ISI - Medical - Technical - Clear

Profile photo for Heather Nichols
Talent Online
Video Narration


ISI copy for iBrance

Vocal Characteristics



Voice Age

Middle Aged (35-54)


North American (General)


Note: Transcripts are generated using speech recognition software and may contain errors.
What is I brands I brands? 125 mg capsules or tablets is a prescription medicine used in adults to treat hormone receptor positive. HR positive human epidermal growth factor receptor two negative her two negative breast cancer. That has spread to other parts of the body metastatic in combination with an aroma teas inhibitor as the first hormonal based therapy in postmenopausal women or in men or full vestment and people with disease progression following hormonal therapy. Important safety information for I brands. I brands may cause serious side effects including low white blood cell counts, neutropenia. Low white blood cell counts are very common when taking I brands and may cause serious infections that can lead to death. Your doctor should check your white blood cell counts before and during treatment. If you develop low white blood cell counts during treatment with I brands, your doctor may stop your treatment, decrease your dose or may tell you to wait to begin your treatment cycle. Tell your doctor right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills, lung problems. Pneumonitis, I brands may cause severe inflammation of the lungs. During treatment that can lead to death. Tell your doctor right away if you have any new or worsening symptoms including chest pain, cough with or without mucus, trouble breathing or shortness of breath. Your doctor may interrupt or stop treatment with eyebrows completely. If your symptoms are severe before you take I brands, tell your doctor about all of your medical conditions, including if you have fever chills or any other signs or symptoms of infection, Have liver or kidney problems are pregnant or plan to become pregnant. I brands can harm your unborn baby. Females who are able to become pregnant should use effective birth control during treatment and for at least three weeks after the last dose of I brands. Your doctor may ask you to take a pregnancy test before you start treatment with my brands. Males with female partners who can become pregnant should use effective birth control during treatment with I brands for at least three months after the last dose of I brands are breastfeeding or plan to breastfeed. It is not known if I brands passes into your breast milk. Do not breastfeed during treatment with I brands and for three weeks after the last dose. The most common side effects of I brands include low red blood cell counts and low platelet counts. Call your doctor right away if you develop any of these symptoms during treatment, dizziness, shortness of breath, weakness, bleeding or bruising more easily nosebleeds. Other most common side effects include infections, tiredness, nausea, sore mouth abnormalities and liver blood tests, diarrhea, hair thinning or hair loss, vomiting, rash, loss of appetite. I brands may cause fertility problems in males. This may affect your ability to father a child, talk to your healthcare provider about family planning options before starting I brands. If this is a concern for you, these are not all of the possible side effects of I brands. For more information, ask your doctor, tell your doctor about all of the medicines you take, including prescription and over the counter medicines, vitamins and herbal supplements I brands and other medicines may affect each other, causing side effects. Do not drink grapefruit juice or eat grapefruit products while taking I brands as they may increase the amount of my brands in your blood. Tell your doctor. If you start a new medicine, take I brands exactly as your doctor tells you. If you take too much I brands call your doctor right away or go to the nearest hospital emergency room. Please click link above for full prescribing information and patient information.